Emre Kucukkose
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Analysis of experimental colorectal liver metastases identifies distinct proliferation-independent transcriptional programs in micro- versus macrometastases.
Journal: Journal of translational medicine
Published: May 13, 2025
A unique interplay of access and selection shapes peritoneal metastasis evolution in colorectal cancer.
Journal: bioRxiv : the preprint server for biology
Published: October 10, 2024
Anti-PD-1 treatment response is associated with the influx of circulating myeloid and T-cell subsets into the metastatic melanoma tumor microenvironment.
Journal: British journal of cancer
Published: May 31, 2024
BRAFV600E augments WNT signaling in colorectal cancer via aberrant DNA methylation.
Journal: iScience
Published: February 20, 2024
Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer.
Journal: British journal of cancer
Published: April 17, 2023
Lymphatic Invasion of Plakoglobin-Dependent Tumor Cell Clusters Drives Formation of Polyclonal Lung Metastases in Colon Cancer.
Journal: Gastroenterology
Published: October 21, 2022
Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice.
Journal: Journal for immunotherapy of cancer
Published: September 30, 2022
BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesis.
Journal: Cell reports
Published: June 22, 2022
KIT promotes tumor stroma formation and counteracts tumor-suppressive TGFβ signaling in colorectal cancer.
Journal: Cell death & disease
Published: April 08, 2022
Mismatch Repair Status in Patient-Derived Colorectal Cancer Organoids Does Not Affect Intrinsic Tumor Cell Sensitivity to Systemic Therapy.
Journal: Cancers
Published: September 27, 2021
A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research.
Journal: Cancer treatment reviews
Published: October 27, 2020
Last Updated: 09/26/2026